QCM Cayman, Ltd.
- SEC CIK
- 0001166340
- Latest filing
- Nov 4, 2024
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by QCM Cayman, Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q3 2024 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −201−100.0% | Sold out | Holders |
| Q2 2024 | 201 | $211.3K | 2.3% | +201 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −256−100.0% | Sold out | Holders |
| Q3 2023 | 256 | $210.7K | 1.4% | −150−36.9% | Reduced | Holders |
| Q2 2023 | 406 | $291.7K | 1.7% | +406 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −422−100.0% | Sold out | Holders |
| Q3 2022 | 422 | $291.0K | 4.3% | +422 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −513−100.0% | Sold out | Holders |
| Q1 2022 | 513 | $358.0K | 1.6% | +72+16.3% | Added | Holders |
| Q4 2021 | 441 | $279.0K | 1.7% | +441 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −449−100.0% | Sold out | Holders |
| Q2 2021 | 449 | $251.0K | 0.6% | +449 | New | Holders |